Vascular Calcifi cation in Chronic Kidney Disease
Turkish Nephrology Dialysis Transplantation · 2010
DOI: 10.5262/tndt.2010.1002.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Nephrology Dialysis Transplantation, 2010. Verfasst von Kultigin Turkmen und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The most common cause of death in patients with end-stage renal disease is cardiovascular (CV) disease. Vascular calcifi cation (VC) is a CV risk factor among dialysis patients. Advanced age, dialysis adequacy, vitamin D therapy and calcium-containing phosphate binders are additional clinical risk factors associated with VC. However, VC is a dynamic and programmed process and cannot only be attributed to passive calcium phosphate deposition. Osteoprotegerin, receptor activator nuclear factor kB (RANK) and its ligand (RANKL), along with the monocyte colony stimulating factor (M-CSF) and the transcription factor core binding protein (Cbfa-1) play a pivotal role in the control of VC. In contrast, Fetuin-A, matrix Gla protein (MGP) and osteopontin (OPN) can control the inhibition of VC. VC can be diagnosed in clinical practice with multi-detector computed tomography (MDCT) and electron beam computed tomography (EBCT).
Zitieren
APA
Turkmen, K., & Tonbul, H. Z. (2010). Vascular Calcifi cation in Chronic Kidney Disease. Turkish Nephrology Dialysis Transplantation. https://doi.org/10.5262/tndt.2010.1002.02
Vancouver
Turkmen K, Tonbul HZ. Vascular Calcifi cation in Chronic Kidney Disease. Turkish Nephrology Dialysis Transplantation. 2010. doi:10.5262/tndt.2010.1002.02
BibTeX
@article{Turkmen2010,
author = {Turkmen, Kultigin and Tonbul, Halil Zeki},
title = {Vascular Calcifi cation in Chronic Kidney Disease},
journal = {Turkish Nephrology Dialysis Transplantation},
year = {2010},
doi = {10.5262/tndt.2010.1002.02}
}
EUVIMED